BDX Jan 2025 280.000 put
| Previous Close | 43.70 |
| Open | 43.70 |
| Bid | 43.90 |
| Ask | 47.50 |
| Strike | 280.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 43.70 - 43.70 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 30 |
PR NewswireWomen in U.S. Can Now Collect Their Own Sample for Cervical Cancer Screening
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) approval for the use of self-collected vaginal specimens for human papillomavirus (HPV) testing when cervical specimens cannot otherwise be obtained. The approval allows women to self-collect vaginal specimens for HPV testing in a health care setting, which could include non-traditional locations such as a retail pharmacy or mobile clinic.
Insider Monkey11 Best Recession Dividend Stocks To Buy
In this article, we discuss 11 best recession dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their past performance during recessionary periods, and go directly to read 5 Best Recession Dividend Stocks To Buy. Several financial analysts, previously forecasting a recession in the US at the end of 2022, […]
Simply Wall St.Results: Becton, Dickinson and Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Becton, Dickinson and Company ( NYSE:BDX ) last week reported its latest quarterly results, which makes it a good time...
